These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 884937

  • 1. [The use of imolamine in intravenous administration is ischemic cardiopathy].
    Catenazzo G, Tadini G, Mantero O.
    Clin Ter; 1977 Jun 15; 81(5):433-51. PubMed ID: 884937
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment with sidnonimine derivatives of chronic ischemic heart disease patients].
    Kuz'ko NV.
    Vrach Delo; 1984 Jul 15; (7):79-81. PubMed ID: 6548063
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of molsidomin in ischemic cardiopathy].
    Di Giacomo G, Nicolella U, Puligheddu M, Tripodi A, D'Ascoli C, Di Virgilio D.
    Clin Ter; 1984 Oct 31; 111(2):141-6. PubMed ID: 6239736
    [No Abstract] [Full Text] [Related]

  • 4. [Imolamine in acute coronary insufficiency. Some considerations in the light of 30 treated cases].
    Caporicci D.
    Clin Ter; 1977 Mar 31; 80(6):553-85. PubMed ID: 862356
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Molsidomin in coronary disease. Clinico-pharmacokinetic correlation study on the effect of oral and sublingual therapy].
    Strasser R, Klepzig H, Ostrowski J, Resag K.
    MMW Munch Med Wochenschr; 1983 Feb 25; 125(8):156-8. PubMed ID: 6405248
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of severe coronary insufficiency with carbochromen].
    Friese G.
    Arzneimittelforschung; 1970 Mar 25; 20():451-3. PubMed ID: 5468730
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical experiences with the use of carbochromen in coronary syndrome].
    Ivancić R, Persić T, Custović F.
    Arzneimittelforschung; 1970 Mar 25; 20():454-6. PubMed ID: 4916580
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.